Skip to main content

Distinguished Speaker Series | Lucie Y. Guo, MD PhD

-
Location
https://ucihealth.zoom.us/j/93299869607?pwd=XwAuKrHHzpMeoEc4jZLXjvvUQWVDwq.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Brunson Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

NEW LOCATION FOR THIS FRIDAY

Thorp Conference Room

Gross Hall, 4th Floor

Irvine, CA 92697

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

November 6, 2026 | Lucie Y. Guo, MD, PhD

Synthetic Biology for Ophthalmic Gene Therapy  

 

Learn More About the Distinguished Speaker Series

Featured


Lucie Y. Guo, MD, PhD
Lucie Y. Guo, MD, PhD
  • Lucie Y. Guo, MD, PhD, Assistant Professor of Ophthalmology, Perelman School of Medicine, University of Pennsylvania

Lucie Y. Guo, M.D., Ph.D., is a physician scientist whose research advances genome and epigenome engineering, synthetic biology, and gene therapy for retinal degenerative diseases. She earned her M.D. and Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania and currently serves as Assistant Professor of Ophthalmology at the University of Pennsylvania. Dr. Guo completed her ophthalmology residency and vitreoretinal surgery fellowship at Stanford University, where she developed novel CRISPR platforms for retinal gene regulation and editing, including the hyperCas12a system for multiplexed genome regulation in the retina. Throughout her career, she has combined expertise in chromatin biology, genome engineering, and clinical retina care to better understand and treat retinal degeneration. Her laboratory focuses on developing next generation gene therapies that enable precise, programmable, and durable gene regulation in the eye, with the goal of creating new therapeutic approaches for complex retinal diseases.